Dr. Malcolm Bates, Partner and Head of Life Sciences, Taylor Wessing LLP
Innovative licensing strategies in commercialising gene-based medicines
Dr. Peter Nolan, Director and Senior Vice President, Commercial Development, Oxford BioMedica plc
Innovative licensing strategies in commercialising gene-based medicines
Monika Vnuk, Senior Director, Business Development, Pfizer
Doing Business Development in Emerging Markets
Henrik Ørum, VP & CSO, Santaris Pharma A/S
MicroRNA Therapeutics: A novel class of therapeutic targets?
Helena Vieira, CEO, BioAlvo
Pitching Perfectly: How Biotechs Can Engage More Successfully With Big Pharma
Fiona Marston, CEO, Absynth
Exploiting Genomics to Prevent & Treat Bacterial Infections
Fiona Marston, CEO, Absynth
Exploiting Synergies to Develop Treatments for Staphylococcus aureus
eith Powell, CEO, Polytherics and Dr. Arvind Hundal, Director of Business Development, Zealand Pharma
Innovative Biotech Showcase
Dr. Barbara Domayne-Hayman, CEO, Stabilitech
Polytherics And Zealand Pharma Collaborate On Novel Optimised Biopharmaceuticals
Dr. Nils P Debus, Office of Technology, Bayer Schering Pharma AG
Focus On Early Biotech Deals